Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 22747910)

1.

Mesoporous silica nanoparticles in biomedical applications.

Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI.

Chem Soc Rev. 2012 Apr 7;41(7):2590-605. doi: 10.1039/c1cs15246g. Epub 2012 Jan 3. Review.

PMID:
22216418
2.

Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.

Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M.

Nanomedicine (Lond). 2012 Jan;7(1):111-20. doi: 10.2217/nnm.11.166. Review.

PMID:
22191780
3.

Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.

Lee JE, Lee N, Kim T, Kim J, Hyeon T.

Acc Chem Res. 2011 Oct 18;44(10):893-902. doi: 10.1021/ar2000259. Epub 2011 Aug 17. Review.

PMID:
21848274
4.

The effects of polymeric nanostructure shape on drug delivery.

Venkataraman S, Hedrick JL, Ong ZY, Yang C, Ee PL, Hammond PT, Yang YY.

Adv Drug Deliv Rev. 2011 Nov;63(14-15):1228-46. doi: 10.1016/j.addr.2011.06.016. Epub 2011 Jul 6. Review.

PMID:
21777633
5.

Polymer nanoneedle-mediated intracellular drug delivery.

Kolhar P, Doshi N, Mitragotri S.

Small. 2011 Jul 18;7(14):2094-100. doi: 10.1002/smll.201100497. Epub 2011 Jun 22.

PMID:
21695782
6.

The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.

Huang X, Li L, Liu T, Hao N, Liu H, Chen D, Tang F.

ACS Nano. 2011 Jul 26;5(7):5390-9. doi: 10.1021/nn200365a. Epub 2011 Jun 8.

PMID:
21634407
7.

Impact of silica nanoparticle design on cellular toxicity and hemolytic activity.

Yu T, Malugin A, Ghandehari H.

ACS Nano. 2011 Jul 26;5(7):5717-28. doi: 10.1021/nn2013904. Epub 2011 Jun 8.

8.

Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.

Meng H, Yang S, Li Z, Xia T, Chen J, Ji Z, Zhang H, Wang X, Lin S, Huang C, Zhou ZH, Zink JI, Nel AE.

ACS Nano. 2011 Jun 28;5(6):4434-47. doi: 10.1021/nn103344k. Epub 2011 May 12.

9.

Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.

Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Qing Max Lu G.

Nanoscale. 2011 Jul;3(7):2801-18. doi: 10.1039/c1nr10224a. Epub 2011 May 5. Review.

PMID:
21547299
10.

Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.

Rosenholm JM, Sahlgren C, Lindén M.

Curr Drug Targets. 2011 Jul 1;12(8):1166-86. Review.

PMID:
21443474
11.

Rapid synthesis of SBA-15 rods with variable lengths, widths, and tunable large pores.

Johansson EM, Ballem MA, Córdoba JM, Odén M.

Langmuir. 2011 Apr 19;27(8):4994-9. doi: 10.1021/la104864d. Epub 2011 Mar 17.

PMID:
21413751
12.

Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.

Liu T, Li L, Teng X, Huang X, Liu H, Chen D, Ren J, He J, Tang F.

Biomaterials. 2011 Feb;32(6):1657-68. doi: 10.1016/j.biomaterials.2010.10.035. Epub 2010 Nov 19.

PMID:
21093905
13.

Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.

Rosenholm JM, Sahlgren C, Lindén M.

Nanoscale. 2010 Oct;2(10):1870-83. doi: 10.1039/c0nr00156b. Epub 2010 Aug 23. Review.

PMID:
20730166
14.

Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.

Lin YS, Haynes CL.

J Am Chem Soc. 2010 Apr 7;132(13):4834-42. doi: 10.1021/ja910846q.

PMID:
20230032
15.

An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.

He Q, Shi J, Chen F, Zhu M, Zhang L.

Biomaterials. 2010 Apr;31(12):3335-46. doi: 10.1016/j.biomaterials.2010.01.015. Epub 2010 Jan 27.

PMID:
20106517
16.

Effect of surface properties on nanoparticle-cell interactions.

Verma A, Stellacci F.

Small. 2010 Jan;6(1):12-21. doi: 10.1002/smll.200901158. Review.

PMID:
19844908
17.

The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.

Huang X, Teng X, Chen D, Tang F, He J.

Biomaterials. 2010 Jan;31(3):438-48. doi: 10.1016/j.biomaterials.2009.09.060. Epub 2009 Oct 1.

PMID:
19800115
18.

Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.

Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M.

Nano Lett. 2009 Sep;9(9):3308-11. doi: 10.1021/nl901589y.

PMID:
19736973
19.

Targeting of porous hybrid silica nanoparticles to cancer cells.

Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Lindén M.

ACS Nano. 2009 Jan 27;3(1):197-206. doi: 10.1021/nn800781r.

PMID:
19206267
20.

In drug delivery, shape does matter.

Mitragotri S.

Pharm Res. 2009 Jan;26(1):232-4. doi: 10.1007/s11095-008-9740-y. Epub 2008 Oct 16. No abstract available.

PMID:
18923811
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk